Biological and Clinical Implications of TNF-α Promoter and CYP1B1 Gene Variations in Coronary Artery Disease Susceptibility.
Rashid MirImadeldin ElfakiChandan K JhaJamsheed JavidAbdullatif T BabakrShaheena BanuMohammad M MirDheeraj JamwalNaina KhullarKhalid J AlzahraniSukh M S ChahalPublished in: Cardiovascular & hematological disorders drug targets (2022)
It was reported that the GA genotype of the CYP1B1 rs1056827 G>T was strongly associated with susceptibility to Coronary Artery Disease with OR= 2.21(1.17 to 4.15)) and p<0.013, and similarly, its A allele was associated with predisposition to CAD with OR = 2.30 (1.55 to 3.42) and p< 0.0001. Our results indicated that TNF-α 1800629 gene polymorphism is not associated with predisposition to Coronary Artery Disease. Nevertheless, these results should be taken with caution and further validated with larger-scale studies before being introduced in the clinical setting.